Effect of Chitosan on Epithelial Cell Tight Junctions Article DOI:
Cite this article as: Smith, J., Wood, E. & Dornish, M. Pharm Res (2004) 21: 43. doi:10.1023/B:PHAM.0000012150.60180.e3 Abstract . Chitosan has been proposed as a novel excipient for transepithelial drug-delivery systems. Chitosan is thought to disrupt intercellular tight junctions, thus increasing the permeability of an epithelium. The effect of chitosan on tight junction complex was investigated at the molecular level. Purpose . Changes in barrier properties of Caco-2 cell monolayers, including transepithelial electrical resistance and permeability to horseradish peroxidase (HRP), were assessed in response to chitosan treatment. Changes in subcellular localization of the tight junction proteins zona occludens 1 (ZO-1) and occludin by immunofluorescence and Western blotting of cellular fractions were also assessed. Methods . Chitosan was found to cause a dose-dependent reduction in transepithelial electrical resistance of Caco-2 monolayers of up to 83%. A corresponding increase in horseradish peroxidase permeability of up to 18 times greater than the control was also observed across the monolayer. Immunofluorescent localization of ZO-1 revealed loss of membrane-associated ZO-1 from discrete areas. Analysis of cellular fractions revealed a dose-dependent loss of ZO-1 and occludin from the cytosolic and membrane fractions into the cytoskeletal fraction. These changes did not occur because of chitosan-mediated ATP depletion. Results
. Chitosan-mediated tight junction disruption is caused by a translocation of tight junction proteins from the membrane to the cytoskeleton. chitosan glutamate tight junctions TEER ZO-1 occludin REFERENCES
O. Skaugrad, A. Hagen, B. Borgersen, and M. Dornish. Biomedical and pharmaceutical applications of alginate and chitosan.
Biotechnol. Genet. Eng. Rev
P. Berscht, B. Nies, A. Leibendorfer, and J. Kreuter. In vitro evaluation of biocompatibility of different wound dressing materials.
J. Mat. Sci. Mater. Med.
M. Dornish, A. Hagen, E. Hansson, C. Pecheur, F. Verdier, and O. Skaugrad. Safety of Protasan: Ultrapure chitosan salts for biomedical and pharmaceutical use. In A. Domard, G. Roberts, and K. Varum (eds.),
Advances of Chitin Sci.
Vol 2. Eds. Jaques Andre, Lyon, 1997, pp. 694-670.
H. Onishi and Y. Machida. Biodegradation and distribution of water-soluble chitosan in mice.
A. Singla and M. Chawla. Chitosan: some pharmaceutical and biological aspects—an update.
J. Pharm. Pharmacol.
N. Kanikkannan, K. Kandimalla, S. Lamba, and M. Singh. Structure-activity relationship of chemical penetration enhancers in transdermal drug delivery.
Curr. Med. Chem.
G. Borchard, H. Lussen, A. deBoer, J. Verhoef, C. Lehr, and H. Junginger. The potential of mucoadhesive polymers in enhancing intestinal peptide drug absorption. III: Effects of chitosan-glutamate and carbomer on epithelial tight junctions in vitro.
J. Control. Release
V. Dodane, M. Amin Khan, and J. Merwin. Effect of chitosan on Caco-2 on epithelial permeability and structure.
Int. J. Pharm.
A. Kotze, H. Lussen, A. de Boer, J. Verhoef, and H. Junginger. Chitosan for enhanced intestinal permeability: prospects for derivatives soluble in neutral and basic environments.
Eur. J. Pharm. Sci.
G. Ranaldi, I. Marigliano, I. Vespignani, G. Perozzi, and Y. Sambuy. The effect of chitosan and other polycations on tight junction permeability in the human intestinal Caco-2 cell line.
J. Nut. Biochem.
A. Shaw. Modelling epithelial tissues in vitro. In A. Shaw (Ed.),
Epithelial Cell Culture: A Practical Approach
. 1st ed. Oxford University Press, Oxford, 1996, pp. 1-16.
B. Denker and S. Nigam. Molecular structure and assembly of the tight junction.
Am. J. Physiol.
M. Cerijido, L. Shoshani, and R. Contreras. Molecular physiology and pathophysiology of tight junctions. I. Biogenesis of tight junctions and epithelial polarity.
Am. J. Physiol.
C. Klingler, U. Kneisel, S. Bamforth, H. Wolburg, B. Engelhardt, and W. Risau. Disruption of epithelial tight junctions is prevented by cyclic nucleotide-dependent protein kinase inhibitors.
Histochem. Cell Biol.
T. Tsukamoto and S. Nigam. Tight junction proteins form large complexes and associate with the cytoskeleton in an ATP depletion model for reversible junction assembly.
J. Biol. Chem.
E. Hughson and R. Hirt. Assessment of cell polarity. In A. Shaw (ed.),
Epithelial Cell Culture: a Practical Approach
. Oxford University Press, New York, 1996, pp. 37-66.
H. Holme, A. Hagen, and M. Dornish. Influence of chitosans on permeability of human intestinal epithelial (Caco-2) cell: the effect of molecular weight and degree of deacetylation and exposure time.
Advan. Chitin Sci
S. Walsh, A. Hopkins, J. Chen, S. Narumiya, C. Parkos, and A. Nusrat. Rho kinase regulates tight junction function and is necessary for tight junction assembly in polarised intestinal epithelia.
J. Turner, E. Black, V. Guerriero, and K. Healewyn. Regulated expression of the myosin light chain kinase catalytic domain increases paracellular permeability and alters tight junction structure.
P. Artursson, T. Lindmark, S. Davis, and L. Illum. Effect of chitosan on the permeability of monolayers of intestinal epithelial cells (Caco-2).
J. Ye, T. Tsukamoto, A. Sun, and S. Nigam. A role for intracellular calcium in tight junction reassembly after ATP depletion-repletion.
Am. J. Physiol.
M. Lekka, P. Laidler, J. Ignacak, M. Labedz, J. Lekki, H. Struszczyk, Z. Stachura, and A. Hrynkiewitz. The effect of chitosan on stiffness and glycolytic activity of human bladder cells.
Biochim. Biophys. Acta
Google Scholar Copyright information
© Plenum Publishing Corporation 2004